Advancing CIK cell immunotherapy: highlights from the second international conference on DC-CIK and CAR-CIK approaches
On April 7, 2025, the 2nd International CIK Cell Conference was held in Monza, Italy, marking the establishment of the International Society for CIK Cells (ISCC). The conference, kindly supported by Fondazione Tettamanti (Italy), featured cutting-edge advancements in cytokine-induced killer (CIK) cell immunotherapy, used alone and in combination with dendritic cells (DC-CIK) and chimeric antigen receptors (CAR-CIK). The event also provided a valuable opportunity for young investigators to engage in insightful discussions and to network within experts in the field.
Authors
- Marta Serafini (ORCID: https://orcid.org/0000-0001-8105-6476)
- Sarah Tettamanti (ORCID: https://orcid.org/0000-0002-7327-418X)
- Martino Introna (ORCID: https://orcid.org/0000-0001-6216-0892)
- Jingjing Pu (ORCID: https://orcid.org/0000-0002-9854-5329)
- Dario Sangiolo (ORCID: https://orcid.org/0000-0002-7163-7071)
- Jian Hou (ORCID: https://orcid.org/0000-0001-8759-8081)
- Alessandro Rambaldi (ORCID: https://orcid.org/0000-0002-3739-7502)
- Antonio Rosato (ORCID: https://orcid.org/0000-0002-5263-8386)
- Kevin Fenix (ORCID: https://orcid.org/0000-0003-1619-1406)
- Xiubao Ren (ORCID: https://orcid.org/0000-0003-4137-2049)
- Ingo G.H. Schmidt‐Wolf
Institutions
- University of Padua (IT)
- Shanghai Jiao Tong University (CN)
- University of Milan (IT)
- University Hospital Bonn (DE)
- Renji Hospital (CN)
- Tianjin Medical University Cancer Institute and Hospital (CN)
- Integrated Oncology (United States) (US)
- Ospedale Papa Giovanni XXIII (IT)
- Istituto Oncologico Veneto (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- University of Turin (IT)
- The University of Adelaide (AU)
Publication Details
- Journal
- Cancer Immunology Immunotherapy
- Published
- 2025-11-03
- DOI
- https://doi.org/10.1007/s00262-025-04216-8
- Citations
- 1
- Primary Topic
- Immune Cell Function and Interaction
- Type
- article
- Field-Weighted Citation Impact
- 0.80
Funders
- Deutsche Krebshilfe